Ken Griffin Mckesson Corp Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$473.42 - $539.26 $41.7 Million - $47.5 Million	-88,000 Reduced 41.35%	124,800 $67 Million
Q4 2023 Feb 14, 2024	BUY	$437.42 - $470.64 $2.76 Million - $2.97 Million	6,300 Added 3.05%	212,800 $98.5 Million
Q3 2023 Nov 14, 2023	BUY	$402.4 - $446.42 $10.3 Million - $11.4 Million	25,600 Added 14.15%	206,500 $89.8 Million
Q2 2023 Aug 14, 2023	BUY	$354.01 - $427.31 $4.64 Million - $5.6 Million	13,100 Added 7.81%	180,900 $77.3 Million
Q1 2023 May 15, 2023	SELL	$335.35 - $386.06 $49.6 Million - $57.1 Million	-148,000 Reduced 46.87%	167,800 $59.7 Million

Q4 2022 Feb 14, 2023	SELL	$346.68 - $397.58 $52.8 Million - $60.6 Million	-152,400 Reduced 32.55%	315,800 $118 Million
Q3 2022 Nov 14, 2022	BUY	$321.25 - $373.84 $33.8 Million - $39.3 Million	105,100 Added 28.95%	468,200 $159 Million

1,675

109M

676K

678K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $84.1B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.